Autor(es):Mostrar menos -

Sabino, Caetano P. ; Ribeiro, Martha S. ; Wainwright, Mark ; Dos Anjos, Carolina ; Sellera, Fabio P. ; Dropa, Milena ; Nunes, Nathalia B. ; Brancini, Guilherme T. P. ; Braga, Gilberto U. L. ; Arana-Chavez, Victor E. ; Freitas, Raul O. ; Lincopan, Nilton ; Baptista, Mauricio S.

• Tipo de documento: Artigo Científico
• Fonte: Photochemistry and Photobiology; v. N/A, p. 9-pg., 2022-08-12.

Resumo

The unbridled dissemination of multidrug-resistant pathogens is a major threat to global health and urgently demands novel therapeutic alternatives. Antimicrobial photodynamic therapy (aPDT) has been developed as a promising approach to treat localized infections regardless of drug resistance profile or taxonomy. Even though this technique has been known for more than a century, discussions and speculations regarding the biochemical mechanisms of microbial inactivation have never reached a consensus on what is the primary cause of cell death. Since photochemically generated oxidants promote ubiquitous reactions with various biomolecules, researchers simply assumed that all cellular structures are equally damaged. In this study, biochemical, molecular, biological and advanced microscopy techniques were employed to investigate whether protein, membrane or DNA damage correlates better with dose-dependent microbial inactivation kinetics. We showed that although mild membrane permeabilization and late DNA damage occur, no correlation with inactivation kinetics was found. On the other hand, protein degradation was analyzed by three different methods and showed a dose-dependent trend that matches microbial inactivation kinetics. Our results provide a deeper mechanistic understanding of aPDT that can guide the scientific community toward the development of optimized photosensitizing drugs and also rationally propose synergistic combinations with antimicrobial chemotherapy. (AU)

• Processo FAPESP: 16/25095-2 - Fotoinativação bacteriana de patógenos da mastite por meio da luz azul: mecanismos de ação e segurança celular - estudo pré clínico
• Beneficiário: Carolina dos Anjos
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 17/22406-0 - Desenvolvimento de equipamento inteligente para aplicação clínica de fototerapias com ajuste dosimétrico automático e pagamento sob demanda
• Beneficiário: Caetano Padial Sabino
• Modalidade de apoio: Auxílio à Pesquisa - Pesquisa Inovativa em Pequenas Empresas - PIPE
• Processo FAPESP: 16/08593-9 - Pan-resistoma de Klebsiella pneumoniae e Escherichia coli produtoras de beta-lactamases (KPC-2, CTX-M-8, CTX-M-15) endêmicas no Brasil
• Beneficiário: Nilton Erbet Lincopan Huenuman
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 13/07937-8 - Redoxoma
• Beneficiário: Ohara Augusto
• Modalidade de apoio: Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs
• Processo FAPESP: 19/10851-4 - Atividade sinérgica da luz azul em combinação com agentes antimicrobianos contra patógenos resistentes
• Beneficiário: Carolina dos Anjos
• Modalidade de apoio: Bolsas no Exterior - Estágio de Pesquisa - Doutorado